| Cash Flow | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income | 1,121,040 | 2,858,794 | 1,770,378 | 945,851 |
| Impairment of goodwill and purchased intangible assets | - | 239,100 | 239,100 | - |
| Depreciation and amortization | 97,016 | 297,836 | 199,745 | 95,823 |
| Unrealized foreign exchange loss and other | -12,078 | -23,622 | -19,064 | -7,718 |
| Stock-based compensation expense | 70,182 | 193,742 | 123,541 | 61,700 |
| Net gain on sale of assets | - | 161 | 161 | - |
| Deferred income taxes | -10,615 | -186,095 | -150,658 | -81,682 |
| Settlement of treasury lock agreement | - | 0 | - | - |
| Accounts receivable | 12,575 | 300,289 | 486,264 | 91,660 |
| Inventories | 95,738 | 106,651 | -5,632 | 59,326 |
| Other assets | -50,921 | -76,105 | -61,796 | -152,641 |
| Accounts payable | -23,680 | 42,390 | 54,617 | -12,463 |
| Deferred system revenue | 1,974 | -117,512 | 86,709 | -108,648 |
| Deferred service revenue | -4,970 | 64,610 | 58,790 | 35,863 |
| Other liabilities | -44,042 | -168,579 | -137,536 | 49,421 |
| Net cash provided by operating activities | 1,161,591 | 2,916,912 | 1,844,753 | 995,238 |
| Proceeds from sale of assets | - | 161 | 161 | - |
| Business acquisitions, net of cash acquired | - | 0 | - | - |
| Acquisition of intellectual property | - | 2,850 | - | - |
| Capital expenditures | 95,894 | 234,851 | 152,716 | 60,393 |
| Proceeds from capital-related government assistance | 1,541 | 315 | - | - |
| Purchases of available-for-sale and equity securities | 949,871 | 2,024,564 | 1,326,968 | 837,935 |
| Proceeds from sale of available-for-sale securities | - | 331,504 | 238,419 | 55,322 |
| Proceeds from maturity of available-for-sale securities | - | 2,061,056 | 1,682,585 | 671,925 |
| Proceeds from maturity and sale of available-for-sale securities | 632,795 | - | - | - |
| Purchases of trading securities | 156,864 | 88,275 | 34,857 | 17,581 |
| Proceeds from sale of trading securities | 158,305 | 79,384 | 36,043 | 17,623 |
| Proceeds from other investments | - | 984 | - | - |
| Net cash used in investing activities | -409,988 | 122,864 | 442,667 | -171,039 |
| Proceeds from issuance of debt, net of issuance costs | - | 0 | - | - |
| Repayment of debt | - | 750,000 | 750,000 | - |
| Payment of debt issuance costs | 1,602 | - | - | - |
| Common stock repurchases | 545,067 | 1,724,249 | 1,217,504 | 567,383 |
| Payment of dividends to stockholders | 254,008 | 650,629 | 424,855 | 198,079 |
| Issuance of common stock | - | 47,538 | 47,538 | - |
| Tax withholding payments related to vested and released restricted stock units | 81,122 | 78,534 | 75,854 | 72,246 |
| Contingent consideration payable and other, net | - | 0 | 0 | - |
| Net cash used in financing activities | -881,799 | -3,155,874 | -2,420,675 | -837,708 |
| Effect of exchange rate changes on cash and cash equivalents | -2,501 | -3,009 | -5,596 | 13,582 |
| Net increase (decrease) in cash and cash equivalents | -132,697 | -119,107 | -138,851 | 73 |
| Cash and cash equivalents at beginning of period | 2,078,908 | 1,977,129 | 1,977,129 | 1,977,129 |
| Cash and cash equivalents at end of period | 1,946,211 | 1,858,022 | 1,838,278 | 1,977,202 |
KLA CORP (KLAC)
KLA CORP (KLAC)